A Study to Evaluate the Safety and Efficacy of JCAR017 in Pediatric Subjects With Relapsed/Refractory (r/r) B-cell Acute Lymphoblastic Leukemia (B-ALL) and B-cell Non-Hodgkin Lymphoma (B-NHL)

Local Institution - 160, New York

Local Institution - 602, Marseille

Local Institution - 501, Berlin

Local Institution - 162, Philadelphia

Local Institution - 301, Monza

Local Institution - 250, Madrid

Local Institution - 166, St. Petersburg

Local Institution - 168, Wauwatosa

Local Institution - 601, Lyon

Local Institution - 600, Paris

Local Institution - 165, Houston

Local Institution - 163, Duarte

Local Institution - 167, Redwood City

Local Institution - 161, Seattle

Local Institution - 164, Dallas

Local Institution - 500, Frankfurt

Local Institution - 300, Roma

Local Institution - 400, Utrecht

Local Institution - 251, Esplugues de Llobregat